CD8+ TILs and Breast Cancer: Identifying New Opportunities for Immunotherapeutic Intervention

In this webinar, Dr. Egelston discusses recent efforts to isolate and characterize phenotypically and functionally exhausted CD8+ TILs from a subset of breast tumors.
Publish Date: August 30, 2019 Views: 9